ACE and hydrops fetalis: Despite the proven efficacy of the angiotensin-converting enzyme inhibitor (ACEI) in the treatment of adults with HF, evidence for their efficacy in treating HF in children is inconclusive and is based on only a few studies with mostly contentious designs and small sample sizes in the newborn and infant populations [3].